SEC Form D · filed March 25, 2021
Enlaza Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Tighe Reardon · La Jolla, CAExecJay Lichter · La Jolla, CADirectorShelley Chu · La Jolla, CADirectorMarcos Milla · La Jolla, CADirectorJames N. Topper · La Jolla, CADirectorSanford Madigan · La Jolla, CAExecSergio Duron · La Jolla, CAExec · DirectorBrian M. Laden · Nashville, TNDirectorByron M. Smith · Nashville, TNExecMark S. Rosen · Morristown, NJDirectorGerard M. Hayden, Jr · Nashville, TNExecRegan Bozman · San Francisco, CAExec · DirectorTyler M. Whitmore · Nashville, TNDirectorChristopher Rand · Nashville, TNDirectorMarc Chalfin · Miami Beach, FLExec · DirectorTheodore Woo · Miami Beach, FLExecMarc Chalfin · Miami Beach, FLExecEric C. Harweger · Ames, IADirectorDavid R. Phaup · Edwardsville, ILDirectorBruce E. Schneider · Venedy, ILDirectorMike D. Christensen · Edwardsville, ILDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗